» Articles » PMID: 3289570

Role of the Major Histocompatibility Complex Class I Antigens in Tumor Growth and Metastasis

Overview
Date 1988 Jan 1
PMID 3289570
Citations 57
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Dynamically Consistent Nonstandard Difference Scheme for a Discrete-Time Immunogenic Tumors Model.

Khan M, Samreen M, Khan M, De la Sen M Entropy (Basel). 2022; 24(7).

PMID: 35885172 PMC: 9317731. DOI: 10.3390/e24070949.


Kawasaki Disease Patient Stratification and Pathway Analysis Based on Host Transcriptomic and Proteomic Profiles.

Jackson H, Menikou S, Hamilton S, McArdle A, Shimizu C, Galassini R Int J Mol Sci. 2021; 22(11).

PMID: 34073389 PMC: 8198135. DOI: 10.3390/ijms22115655.


Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.

Yang S, Chen L, Chan D, Li Q, Zhang H Clin Proteomics. 2017; 14:31.

PMID: 28814946 PMC: 5557576. DOI: 10.1186/s12014-017-9166-9.


SST-2 tumor inoculation is a useful model for studying the anti-tumor immune response in SHR rats.

Nishio N, Oishi K, Machida K Environ Health Prev Med. 2011; 8(1):1-5.

PMID: 21432108 PMC: 2723258. DOI: 10.1007/BF02897936.


In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.

Riond J, Rodriguez S, Nicolau M, Al Saati T, Gairin J Cancer Immun. 2009; 9:10.

PMID: 19877577 PMC: 2935763.